Current investigations for liver fibrosis treatment: between repurposing the FDA-approved drugs and the other emerging approaches
Long-term liver injuries lead to hepatic fibrosis, often progressing into cirrhosis, liver failure, portal hypertension, and hepatocellular carcinoma. There is currently no effective therapy available for liver fibrosis. Thus, continuous investigations for anti-fibrotic therapy are ongoing. The main...
Guardat en:
| Autors principals: | , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Frontiers Media S.A.
2023-11-01
|
| Col·lecció: | Journal of Pharmacy & Pharmaceutical Sciences |
| Matèries: | |
| Accés en línia: | https://www.frontierspartnerships.org/articles/10.3389/jpps.2023.11808/full |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|